ONTX - Onconova Therapeutics to Present at NobleCon19 Noble Capital Markets' Nineteenth Annual Emerging Growth Equity Conference | Benzinga
NEWTOWN, Pa., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), ("Onconova", the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that Steven Fruchtman, M.D., President & CEO, will present at NobleCon19, Noble Capital Markets' Nineteenth Annual Emerging Growth Equity Conference, being held December 3-5, 2023 at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL.
Presentation Details
| Date/Time: |
| Monday, December 4, 2023, 10:30 AM ET followed by a Breakout Session |
| Speaker: |
| Steven Fruchtman, M.D., President & CEO |
| 1X1 meetings: |
| The Onconova Management Team will be available for 1X1 meetings during the conference. Those interested in requesting a meeting should contact their ... |